SCHEMBL6418607

SCHEMBL6418607

COc1ccc(C=C2SC(=N)NC2=O)cc1O

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.81
MEN1 O00255 1/20 0.81
KMT2A Q03164 1/20 0.81
GSK3B P49841 5/20 0.64
PIM1 P11309 4/20 0.64
PIM3 Q86V86 4/20 0.64
PIM2 Q9P1W9 4/20 0.64
CDC7 O00311 3/20 0.64
DAPK3 O43293 3/20 0.64
DYRK3 O43781 3/20 0.64
MAP4K4 O95819 3/20 0.64
RPS6KB1 P23443 3/20 0.64
CSNK1D P48730 3/20 0.64
CLK2 P49760 3/20 0.64
GSK3A P49840 3/20 0.64
CSNK1G2 P78368 3/20 0.64
CAMK2D Q13557 3/20 0.64
DYRK1A Q13627 3/20 0.64
MINK1 Q8N4C8 3/20 0.64
HIPK4 Q8NE63 3/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15421721 1.00 POLB (0.81) POLBMEN1KMT2AGSK3BPIM1
SCHEMBL6418603 1.00 POLB (0.81) POLBMEN1KMT2AGSK3BPIM1
SCHEMBL6412182 0.90 MEN1 (1.00) POLBMEN1KMT2AGSK3BPIM1
SCHEMBL15421863 0.90 MEN1 (1.00) POLBMEN1KMT2AGSK3BPIM1
SCHEMBL6412187 0.90 MEN1 (1.00) POLBMEN1KMT2AGSK3BPIM1
SCHEMBL15421529 0.88 MEN1 (0.79) POLBMEN1KMT2AGSK3BPIM1
SCHEMBL15421530 0.88 MEN1 (0.79) POLBMEN1KMT2AGSK3BPIM1
SCHEMBL15421752 0.88 PIM1 (0.80) POLBMEN1KMT2AGSK3BPIM1
SCHEMBL15421753 0.88 PIM1 (0.80) POLBMEN1KMT2AGSK3BPIM1
SCHEMBL15421754 0.88 PIM1 (0.80) POLBMEN1KMT2AGSK3BPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050019825-A9 Common ligand mimics: pseudothiohydantoins TRIAD THERAPEUTICS, INC. 2005-01-27 US disclosed
US-20040009527-A1 Common ligand mimics: pseudothiohydantoins DONG QING (US) 2004-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050019825-A9 Common ligand mimics: pseudothiohydantoins FGFR3, BID, FLT3 POLB 4859/4885MEN1 1966/4885KMT2A 3032/4885
US-20040009527-A1 Common ligand mimics: pseudothiohydantoins FGFR3, BID, FLT3 POLB 4859/4885MEN1 1966/4885KMT2A 3032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.